D. Greenberg

发表

Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.

B. Ponder, D. Easton, C. Caldas, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates?

P. Pharoah, D. Greenberg, F. Blows, 2009, British Journal of Cancer.

Effects of Common Germ-Line Genetic Variation in Cell Cycle Genes on Ovarian Cancer Survival

A. Whittemore, D. Easton, D. Greenberg, 2008, Clinical Cancer Research.

Are Transrectal Prostate Biopsies Routinely Indicated in Patients with Incidentally Diagnosed Prostate Cancer following Transurethral Resection of the Prostate for Benign Disease?

D. Greenberg, V. Gnanapragasam, A. Warren, 2013, Urologia Internationalis.

Patient and tumour characteristics, management, and age-specific survival in women with breast cancer in the East of England

P. Pharoah, D. Greenberg, A. Ali, 2011, British Journal of Cancer.

Prostate-specific antigen testing for prostate cancer screening: A national survey of Canadian primary care physicians' opinions and practices.

D. Greenberg, S. Goldenberg, Elise M. Fryml, 2017, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Common germline variation in mismatch repair genes and survival after a diagnosis of colorectal cancer

D. Easton, P. Pharoah, D. Greenberg, 2009, International journal of cancer.

Urinary symptoms and prostate cancer—the misconception that may be preventing earlier presentation and better survival outcomes

D. Greenberg, N. Burnet, V. Gnanapragasam, 2022, BMC Medicine.

Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival.

M. Beckmann, K. Czene, P. Hall, 2010, Journal of the National Cancer Institute.

A Genome-Wide Association Study of Prognosis in Breast Cancer

Peter Kraft, Stephen J Chanock, Paul D P Pharoah, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Null Results in Brief Cancer Epidemiology , Biomarkers & Prevention A Genome-Wide Association Study of Prognosis in Breast Cancer

S. Chanock, R. Hoover, D. Hunter, 2010 .

Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort

D. Easton, C. Caldas, P. Pharoah, 2008, Breast Cancer Research.

Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort

D M Berney, J Cuzick, J. Cuzick, 2015, British Journal of Cancer.

Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer

Carlos Caldas, Douglas Easton, Alison M Dunning, 2009, International journal of cancer.

Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients.

A. Whittemore, D. Easton, P. Pharoah, 2008, European journal of cancer.

An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation

Ian O. Ellis, Francisco J. Candido dos Reis, Marjanka K. Schmidt, 2017, Breast Cancer Research.

An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation

I. Ellis, A. Green, P. Pharoah, 2017, Breast Cancer Research.

PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2

S. Cross, P. Fasching, J. Olson, 2012, British Journal of Cancer.

Common germline variation in mismatch repair genes and survival after a diagnosis of colorectal cancer

D. Easton, P. Pharoah, D. Greenberg, 2009, International journal of cancer.